Advertisement

Pharmacy World and Science

, Volume 21, Issue 3, pp 147–166 | Cite as

Proceedings – ESCP27 th European Symposium on Clinical Pharmacy Evidence-Based Pharmaceutical Care, 26-28 October 1998, Jerusalem, Israel

Article
  • 58 Downloads

Keywords

Public Health Internal Medicine Clinical Pharmacy European Symposium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cairns C. The effect of patient-focused care on the activities of clinical pharmacists. 3rd Congress of the EAHP, Edingburgh 12-14 March 1998.Google Scholar
  2. 2.
    Zografi G. An essential societal role. The Annuals of Pharmacotherapy 1998; 32: 471-4.Google Scholar
  3. 3.
    Leufkens H, Hekster Y, Hudson S. Scenario analysis of the future of clinical pharmacy. Pharmacy World and Science 1997; 19:182-5.Google Scholar
  4. 4.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43.Google Scholar
  5. 5.
    1st EPSA / ESCP Student Symposium 13 October 1999 Berlin, prior to the 28th Annual Symposium of the ESCP.Google Scholar

References

  1. 1.
    WHO; The role and functions of the community and hospital pharmacist in the health care systems of Europe, Lunde I., Dukes G. Editors. 1989, STYX publications. Postbus 1344, Groningen, The Netherlands.Google Scholar
  2. 2.
    Granados A, Jonsson E, Banta HD et al. EUR-ASSESS project subgroup report on dissemination and impact. Int J Technol Asses Health Care 1997; 13:220-86Google Scholar
  3. 3.
    Pons JMV, Marcadors o resultats intermedis en la mesura de l'efecte de les intervencions mediques. Informatiu AATM 1997;11:11-12Google Scholar
  4. 4.
    Walker R, Outcome measures in patient care pharmaceutical care vs. Pharmaceutical public health. Progress in Clinical Pharmacy: Optimising pharmacotherapy process, Luscombe DK, Husson MC, Caramona M, editors 1997, ESCP publ. Pp 56-59Google Scholar
  5. 5.
    Hekster YA, Pharmacoepidemiology. Scroccaro G, Martini N, Delporte JP, MC, Walker R, editors 1195, ESCP publ. pp. 169-170 Barcelona, SpainGoogle Scholar

References

  1. 1.
    Nobili A, Gebru F, Rossetti A, et al. Doctorline a private toll-free telephone medical information service. Ann Pharmacother 1998; 32:120-5.Google Scholar
  2. 2.
    Nobili A, Macario G.L., Gebru F., et al. Information lines run by doctors are useful. BMJ 1997; 314:904.Google Scholar
  3. 3.
    Nobili A, Macario G.L., Tettamanti M, et al. Un metodo quantitativo di valutazione dell'utilita delle informazioni fornite al medico da un servizio di informazione sul farmaco. Risultati di uno studio pilota condotto dal servizio Doctorline. Giornale Italiano di Farmacologia Clinica 1998; Vol 12(1).Google Scholar
  4. 4.
    Rossetti A, Gebru F, Nobili A, et al. The role of drug information in Doctorline a private toll-free telephone medical information service. E.S.C.P. 4th European Conference on Drug Information. 21-23 May 1997. Amsterdam, The Netherlands.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Personalised recommendations